Tisdag 30 December | 19:52:10 Europe / Stockholm

Prenumeration

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2024-07-08 10:28:00

Redeye maintains a positive outlook on Nanologica following its Q2 report. Production has improved and it seems that the company is poised for growth in the near term. While we mostly maintain our fair value range, we have made some adjustments to our estimates.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/